Search - tctmd.com

Displaying 421 - 440 of 892

Sort: Relevancy | Date

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

Todd Neale

October 10, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Presentation TCT 2019

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Presenter: Seung-Jung Park

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

Presenter: Ron Waksman

September 27, 2019

Presentation TCT 2019

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

Presenter: Francesco Prati

September 27, 2019

Presentation TCT 2019

What is a High Risk PFO, and Should it Affect the Decision to Close?

Presenter: Jonathan Tobis

September 27, 2019

Presentation TCT 2019

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

Presenter: Clifford Kavinsky

September 27, 2019

Presentation TCT 2019

PFO in 2019, A Neurologist’s Perspective

Presenter: David Thaler

September 27, 2019

Presentation TCT 2019

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

Presenter: Andrew Goldsweig, MD

September 27, 2019

Advertisement

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

FDA Gives Rivaroxaban Another VTE-Related Indication

Recurrent Events Common Among Young Patients With CAD

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

What is a High Risk PFO, and Should it Affect the Decision to Close?

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

PFO in 2019, A Neurologist’s Perspective

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content